Summary
- The Controller General of Patents, Designs and Trademarks (CGPDTM) has released new draft guidelines for examining pharmaceutical and biotechnology patent applications.
- Stakeholders are invited to submit comments or suggestions within 15 days, with submissions directed to specific email addresses provided by the CGPDTM.
- The Draft Pharmaceutical Guidelines (2026) significantly update the 2014 version, while the Draft Biotech Guidelines (2026) enhance the 2013 version, reflecting advancements in technology and jurisprudence.
- These updates aim to streamline patenting procedures for healthcare inventions, potentially reshaping the landscape of pharma and biotech patents in India.
Join the discussion — sign up to comment, upvote, and save articles.